Evidence map›Paper›PMID 15039333›Full record

ArticleInfection and immunity2004

Novel program of macrophage gene expression induced by phagocytosis of Leishmania chagasi.

Nilda E Rodriguez, Haeok K Chang, Mary E Wilson

Abstract read
In one paragraph

Article in Infection and immunity, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Immune Responses in Leishmaniasis: An Overview.Tropical medicine and infectious disease · 2022
    Review
  9. Article
  10. Article
  11. Transcription Factors Interplay Orchestrates the Immune-Metabolic Response ofFrontiers in cellular and infection microbiology · 2021
    Review
  12. Article
  13. Model-based Evaluation of Gene Expression Changes in Response toGene regulation and systems biology · 2019
    Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Nilda E RodriguezDepartment of Microbiology, University of Iowa, Iowa City, Iowa 52242, USA.
Haeok K Chang
Mary E Wilson

Funding

TRAINING IN MECHANISMS OF PARASITISMT32AI007511 · NIAID · UNIVERSITY OF IOWA · PI BUTLER, NOAH SULLIVAN, WEBER, MARY · 1996 to 2025
$8.1M
Immunogenetics of Leishmania chagasi InfectionR01AI048822 · NIAID · UNIVERSITY OF IOWA · PI WILSON, MARY EDYTHE · 2001 to 2005
$3.2M
Protective Immunity to Leishmania chagasiR01AI045540 · NIAID · UNIVERSITY OF IOWA · PI WILSON, MARY E · 2001 to 2011
$3.1M
GP63 EXPRESSION IN LEISHMANIA DONOVANI CHAGASIR01AI032135 · NIAID · UNIVERSITY OF IOWA · PI WILSON, MARY EDYTHE · 1992 to 2001
$521k
NIAID NIH HHS R01 AI032135NIAID NIH HHS R01 AI045540NIAID NIH HHS R01 AI048822NIAID NIH HHS R01 AI32135NIAID NIH HHS R01 AI45540NIAID NIH HHS R01-AI48822NIAID NIH HHS T32 AI007511NIAID NIH HHS T32 AI07511
6 · The paper itself

Abstract

Leishmania spp. are protozoans that survive and replicate intracellularly in mammalian macrophages. Antileishmanial immunity requires gamma interferon (IFN-gamma)-mediated macrophage activation and generation of microbicidal effector molecules. The presence of intracellular Leishmania sp. impairs macrophage responses to IFN-gamma, which has led to the description of macrophages as deactivated. It has recently become apparent that in addition to classical activation, macrophages can be activated by distinct triggers to express noninflammatory or anti-inflammatory genes. These nonclassical activation programs have been called alternative or type II pathways. We hypothesized that during initial contact with a phagocyte, leishmaniae activate one of these nonclassical pathways, resulting in expression of genes whose products suppress microbicidal responses. Using DNA microarrays, we studied gene expression in RNAs from BALB/c bone marrow macrophages with and without Leishmania chagasi infection. Some changes were verified by an RNase protection assay, reverse transcription-PCR, immunoblotting, or a bioassay. The pattern of genes activated by leishmania phagocytosis differed from the pattern of genes activated by bacteria or lipopolysaccharide and IFN-gamma. Genes encoding some proinflammatory cytokines, receptors, and Th1-type immune response genes were down-modulated, and some genes associated with anti-inflammatory or Th2-like immune responses were up-regulated. Nonetheless, some markers of alternative (arginase) or type II activation (interleukin-10, tumor necrosis factor alpha) were unchanged. These data suggest that macrophages infected with L. chagasi exhibit a hybrid activation profile that is more characteristic of alternative or type II activation than of classical activation but does not strictly fall into either of these categories. We speculate that the pattern of genes upregulated by leishmania phagocytosis optimizes the chance of parasite survival in this hostile environment.

Indexed as

Gene Expression ProfilingGene Expression RegulationPhagocytosisAnimalsCricetinaeHumansLeishmaniaMacrophage ActivationMacrophagesMaleMesocricetusMiceMice, Inbred BALB COligonucleotide Array Sequence AnalysisProteinsRNA, MessengerProteinsRNA, Messenger

Identifiers

PMID15039333
PMCPMC375188

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.